These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27544904)

  • 1. Reboxetine in therapy-resistant enuresis: A randomized placebo-controlled study.
    Lundmark E; Stenberg A; Hägglöf B; Nevéus T
    J Pediatr Urol; 2016 Dec; 12(6):397.e1-397.e5. PubMed ID: 27544904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A; Pires J; Ellsworth P
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reboxetine in therapy-resistant enuresis: a retrospective evaluation.
    Lundmark E; Nevéus T
    Scand J Urol Nephrol; 2009; 43(5):365-8. PubMed ID: 19921980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of voiding chart data in therapy-resistant enuresis.
    Lundmark E; Neve Us T
    J Pediatr Urol; 2020 Jun; 16(3):353.e1-353.e6. PubMed ID: 32423706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reboxetine in therapy-resistant enuresis: results and pathogenetic implications.
    Nevéus T
    Scand J Urol Nephrol; 2006; 40(1):31-4. PubMed ID: 16452053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricyclic and related drugs for nocturnal enuresis in children.
    Caldwell PH; Sureshkumar P; Wong WC
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002117. PubMed ID: 26789925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with desmopressin and an anticholinergic medication for nonresponders to desmopressin for monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial.
    Austin PF; Ferguson G; Yan Y; Campigotto MJ; Royer ME; Coplen DE
    Pediatrics; 2008 Nov; 122(5):1027-32. PubMed ID: 18977983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
    Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
    BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).
    Deshpande AV; Caldwell PH; Sureshkumar P
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002238. PubMed ID: 23235587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the combined treatment of solifenacin and imipramine has a role in desmopressin refractory monosymptomatic nocturnal enuresis? A prospective double-blind randomized placebo-controlled study.
    Samir M; Mahmoud MA; Elawady H
    Urologia; 2021 Nov; 88(4):369-373. PubMed ID: 33568005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
    Kamperis K; Hagstroem S; Faerch M; Mahler B; Rittig S; Djurhuus JC
    Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of the addition of short-term desmopressin to alarm therapy in the treatment of primary nocturnal enuresis.
    Ozden C; Ozdal OL; Aktas BK; Ozelci A; Altinova S; Memis A
    Int Urol Nephrol; 2008; 40(3):583-6. PubMed ID: 18320340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL; Stokes A; Salzman PM
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotoxicological remedies versus desmopressin versus placebo in the treatment of enuresis: a randomised, double-blind, controlled trial.
    Ferrara P; Marrone G; Emmanuele V; Nicoletti A; Mastrangelo A; Tiberi E; Ruggiero A; Fasano A; Paolini Paoletti F
    Pediatr Nephrol; 2008 Feb; 23(2):269-74. PubMed ID: 17310359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing response to desmopressin in patients with monosymptomatic nocturnal enuresis.
    Kamperis K; Van Herzeele C; Rittig S; Vande Walle J
    Pediatr Nephrol; 2017 Feb; 32(2):217-226. PubMed ID: 27071997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Monosymptomatic Nocturnal Enuresis: Monotherapy vs Combination Therapy.
    Sharifiaghdas F; Sharifiaghdas S; Taheri M
    Urology; 2016 Jul; 93():170-4. PubMed ID: 27018367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.